Dr Lianne Schmaal is Lead, Neuroimaging work-stream section within the Clinical and Translational Neuroscience Research program at Orygen.
Lianne’s research is focused on the neurobiology of depression and suicidal thoughts and behaviours. Her team integrates clinical, psychosocial, neurobiological and genetic data through computational modelling and machine learning methods to develop prediction algorithms for depression onset, treatment response and suicide attempts, and to address the heterogeneity of depression and suicidal thoughts and behaviours.
Lianne leads the two largest neuroimaging consortia on depression and suicidal behaviours worldwide, i.e. the ENIGMA Major Depressive Disorder (MDD) and the ENIGMA Suicidal Thoughts and Behaviours (STB) consortia. These international consortia pool neuroimaging and clinical data from >35,000 people from ~50 research institutes in 15 different countries worldwide.
Neuroimaging, depression, suicide, big data, machine learning